Innovation1 Biotech Inc. (IVBT) Financial Metrics
This dashboard provides comprehensive financial metrics and analysis to help evaluate Innovation1 Biotech Inc.'s investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.
Financial Metrics Score
Valuation Metrics
Sector benchmarks: Industrials
P/E Ratio
-1.21
Burn Risk
P/B Ratio
-5.00
Equity Deficit
Earnings Yield
-34.90%
Yield Gap
Profitability Health
2023Return on Equity
174.58%
Strong
WeakModerateStrong
Operating Margin
-
No data
Net Profit Margin
-
No data
Growth Indicators
2023Revenue Growth
-
No data
Net Income Growth
85.35%
Strong
WeakModerateStrong
EPS Growth
74.36%
Strong
WeakModerateStrong
Efficiency & Liquidity
2023Current Ratio
0.02
Weak
WeakModerateStrong
Quick Ratio
0.02
Weak
WeakModerateStrong
Asset Turnover
-
No data
Inventory Turnover
-
No data
Cash Flow & Resilience
Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes
Free Cash Flow Yield
-3.61%
Weak
WeakModerateStrong
EV / Free Cash Flow
-27.95x
Strong
WeakModerateStrong
Net Debt / EBITDA
-0.03x
Strong
WeakModerateStrong
Interest Burden (EBT / EBIT)
4.380
Strong
WeakModerateStrong
Return on Invested Capital
42.71%
Strong
WeakModerateStrong
Cash Conversion Cycle
-2419.35 days
Strong
WeakModerateStrong
Fortress screener guardrails
3/4 passing
- FCF Yield > 3%
- Net Debt / EBITDA < 1.5x
- ROIC > 20%
- Cash Conversion Cycle < 0 days
Financial Statements
Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for IVBT.
View Financial Statements